APELLIS PHARMACTDL (Germany) Price History
1JK Stock | EUR 27.24 1.35 4.72% |
If you're considering investing in APELLIS Stock, it is important to understand the factors that can impact its price. As of today, the current price of APELLIS PHARMACTDL stands at 27.24, as last reported on the 4th of February, with the highest price reaching 27.24 and the lowest price hitting 27.24 during the day. At this point, APELLIS PHARMACTDL is not too volatile. APELLIS PHARMACTDL 0001 secures Sharpe Ratio (or Efficiency) of 0.0229, which signifies that the company had a 0.0229 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for APELLIS PHARMACTDL 0001, which you can use to evaluate the volatility of the firm. Please confirm APELLIS PHARMACTDL's Mean Deviation of 2.74, risk adjusted performance of 0.0704, and Downside Deviation of 3.26 to double-check if the risk estimate we provide is consistent with the expected return of 0.0921%.
APELLIS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
APELLIS |
Sharpe Ratio = 0.0229
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | 1JK | Huge Risk |
Negative Returns |
Estimated Market Risk
4.02 actual daily | 35 65% of assets are more volatile |
Expected Return
0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average APELLIS PHARMACTDL is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of APELLIS PHARMACTDL by adding it to a well-diversified portfolio.
APELLIS PHARMACTDL Stock Price History Chart
There are several ways to analyze APELLIS Stock price data. The simplest method is using a basic APELLIS candlestick price chart, which shows APELLIS PHARMACTDL price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | December 3, 2024 | 33.05 |
Lowest Price | November 18, 2024 | 24.23 |
APELLIS PHARMACTDL February 4, 2025 Stock Price Synopsis
Various analyses of APELLIS PHARMACTDL's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell APELLIS Stock. It can be used to describe the percentage change in the price of APELLIS PHARMACTDL from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of APELLIS Stock.APELLIS PHARMACTDL Price Action Indicator | (0.68) | |
APELLIS PHARMACTDL Price Rate Of Daily Change | 0.95 |
APELLIS PHARMACTDL February 4, 2025 Stock Price Analysis
APELLIS Stock Price History Data
The price series of APELLIS PHARMACTDL for the period between Wed, Nov 6, 2024 and Tue, Feb 4, 2025 has a statistical range of 8.82 with a coefficient of variation of 9.09. The prices are distributed with arithmetic mean of 28.82. The median price for the last 90 days is 28.49.Open | High | Low | Close | Volume | ||
02/03/2025 | 27.24 | 27.24 | 27.24 | 27.24 | 120.00 | |
01/31/2025 | 28.59 | 28.59 | 28.59 | 28.59 | 120.00 | |
01/30/2025 | 27.65 | 27.65 | 27.65 | 27.65 | 120.00 | |
01/29/2025 | 27.36 | 27.36 | 27.36 | 27.36 | 120.00 | |
01/28/2025 | 27.75 | 27.75 | 27.02 | 27.02 | 120.00 | |
01/27/2025 | 27.76 | 27.76 | 27.76 | 27.76 | 120.00 | |
01/24/2025 | 28.70 | 28.70 | 28.70 | 28.70 | 120.00 | |
01/23/2025 | 28.49 | 28.49 | 28.49 | 28.49 | 1.00 | |
01/22/2025 | 28.26 | 28.26 | 28.26 | 28.26 | 120.00 | |
01/21/2025 | 28.24 | 28.24 | 28.24 | 28.24 | 1.00 | |
01/20/2025 | 28.35 | 28.35 | 28.35 | 28.35 | 120.00 | |
01/17/2025 | 28.23 | 28.23 | 28.23 | 28.23 | 120.00 | |
01/16/2025 | 27.56 | 27.56 | 27.56 | 27.56 | 1.00 | |
01/15/2025 | 26.22 | 26.22 | 26.22 | 26.22 | 1.00 | |
01/14/2025 | 27.23 | 27.24 | 27.23 | 27.24 | 1.00 | |
01/13/2025 | 26.12 | 28.03 | 26.12 | 28.03 | 120.00 | |
01/10/2025 | 30.75 | 30.75 | 30.75 | 30.75 | 1.00 | |
01/09/2025 | 31.30 | 31.30 | 31.30 | 31.30 | 120.00 | |
01/08/2025 | 32.81 | 32.81 | 32.81 | 32.81 | 120.00 | |
01/07/2025 | 32.34 | 32.34 | 32.29 | 32.29 | 120.00 | |
01/06/2025 | 31.75 | 31.75 | 31.75 | 31.75 | 1.00 | |
01/03/2025 | 31.63 | 31.63 | 31.63 | 31.63 | 120.00 | |
01/02/2025 | 30.16 | 30.16 | 30.16 | 30.16 | 120.00 | |
12/30/2024 | 30.55 | 30.55 | 30.55 | 30.55 | 1.00 | |
12/27/2024 | 30.99 | 31.50 | 30.99 | 31.50 | 120.00 | |
12/23/2024 | 31.22 | 31.22 | 31.22 | 31.22 | 120.00 | |
12/20/2024 | 31.24 | 31.24 | 31.24 | 31.24 | 120.00 | |
12/19/2024 | 32.10 | 32.10 | 32.10 | 32.10 | 120.00 | |
12/18/2024 | 32.21 | 32.21 | 32.21 | 32.21 | 120.00 | |
12/17/2024 | 31.28 | 31.28 | 31.28 | 31.28 | 1.00 | |
12/16/2024 | 30.89 | 30.89 | 30.89 | 30.89 | 120.00 | |
12/13/2024 | 30.60 | 30.60 | 30.60 | 30.60 | 120.00 | |
12/12/2024 | 31.58 | 31.82 | 31.58 | 31.82 | 120.00 | |
12/11/2024 | 32.24 | 32.24 | 32.24 | 32.24 | 120.00 | |
12/10/2024 | 32.46 | 32.46 | 32.46 | 32.46 | 120.00 | |
12/09/2024 | 31.04 | 31.04 | 31.04 | 31.04 | 120.00 | |
12/06/2024 | 30.92 | 30.92 | 30.92 | 30.92 | 120.00 | |
12/05/2024 | 31.72 | 31.72 | 31.72 | 31.72 | 120.00 | |
12/04/2024 | 32.30 | 32.30 | 32.30 | 32.30 | 120.00 | |
12/03/2024 | 33.05 | 33.05 | 33.05 | 33.05 | 120.00 | |
12/02/2024 | 30.80 | 30.80 | 30.80 | 30.80 | 120.00 | |
11/29/2024 | 31.62 | 31.62 | 31.62 | 31.62 | 120.00 | |
11/28/2024 | 31.71 | 31.74 | 31.71 | 31.74 | 120.00 | |
11/27/2024 | 30.43 | 30.43 | 30.39 | 30.39 | 120.00 | |
11/26/2024 | 29.77 | 29.77 | 29.77 | 29.77 | 120.00 | |
11/25/2024 | 28.85 | 28.85 | 28.85 | 28.85 | 120.00 | |
11/22/2024 | 25.83 | 25.83 | 25.83 | 25.83 | 120.00 | |
11/21/2024 | 25.51 | 25.56 | 25.50 | 25.56 | 120.00 | |
11/20/2024 | 26.76 | 26.76 | 26.76 | 26.76 | 1.00 | |
11/19/2024 | 25.72 | 28.00 | 25.72 | 28.00 | 1.00 | |
11/18/2024 | 24.23 | 24.23 | 24.23 | 24.23 | 1.00 | |
11/15/2024 | 25.79 | 25.79 | 24.78 | 24.78 | 1.00 | |
11/14/2024 | 26.05 | 26.05 | 26.05 | 26.05 | 1,464 | |
11/13/2024 | 26.78 | 27.59 | 26.78 | 27.59 | 555.00 | |
11/12/2024 | 27.34 | 27.34 | 27.34 | 27.34 | 930.00 | |
11/11/2024 | 27.31 | 27.31 | 27.31 | 27.31 | 1.00 | |
11/08/2024 | 25.97 | 25.97 | 25.97 | 25.97 | 560.00 | |
11/07/2024 | 26.08 | 26.08 | 26.08 | 26.08 | 2,120 | |
11/06/2024 | 25.93 | 27.00 | 25.93 | 27.00 | 8,641 | |
11/05/2024 | 26.52 | 26.52 | 26.52 | 26.52 | 5,229 | |
11/04/2024 | 24.91 | 24.91 | 24.91 | 24.91 | 265.00 |
About APELLIS PHARMACTDL Stock history
APELLIS PHARMACTDL investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for APELLIS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in APELLIS PHARMACTDL 0001 will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing APELLIS PHARMACTDL stock prices may prove useful in developing a viable investing in APELLIS PHARMACTDL
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts. APELLIS PHARMACT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 445 people.
APELLIS PHARMACTDL Stock Technical Analysis
APELLIS PHARMACTDL technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
All Next | Launch Module |
APELLIS PHARMACTDL Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for APELLIS PHARMACTDL's price direction in advance. Along with the technical and fundamental analysis of APELLIS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of APELLIS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0704 | |||
Jensen Alpha | 0.2262 | |||
Total Risk Alpha | (0.04) | |||
Sortino Ratio | 0.0644 | |||
Treynor Ratio | 0.3654 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for APELLIS Stock analysis
When running APELLIS PHARMACTDL's price analysis, check to measure APELLIS PHARMACTDL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy APELLIS PHARMACTDL is operating at the current time. Most of APELLIS PHARMACTDL's value examination focuses on studying past and present price action to predict the probability of APELLIS PHARMACTDL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move APELLIS PHARMACTDL's price. Additionally, you may evaluate how the addition of APELLIS PHARMACTDL to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements |